BCE Inc
BCE
Choice Properties Real Estate Investment Trust
CHP.UN
TELUS Corp
T
4
The Toronto-Dominion Bank
TD
5
Power Corporation of Canada
POW
CA Stock MarketDetailed Quotes
NGMD NuGen Medical Devices Inc
- 0.045
- -0.005-10.00%
15min DelayMarket Closed Apr 4 16:00 ET
9.80MMarket Cap-1.29P/E (TTM)
0.055High0.040Low711.65KVolume0.050Open0.050Pre Close30.59KTurnover0.15552wk High0.33%Turnover Ratio217.73MShares0.04052wk Low-0.035EPS TTM9.57MFloat Cap0.530Historical HighLossP/E (Static)212.76MShs Float0.035Historical Low-0.05EPS LYR30.00%Amplitude--Dividend TTM-1.50P/B1Lot Size--Div YieldTTM
NuGen Medical Devices Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 359.18%531.82K | -33.82%14.92K | 94.43%47.39K | 117.52%331.4K | 667.89%168.66K | 2,775.35%115.82K | -80.52%22.55K | -63.95%24.38K | 10.69%152.36K | -24.15%21.96K |
| Operating revenue | 359.18%531.82K | -33.82%14.92K | 94.43%47.39K | 117.52%331.4K | 667.89%168.66K | 2,775.35%115.82K | -80.52%22.55K | -63.95%24.38K | 10.69%152.36K | -24.15%21.96K |
| Cost of revenue | 535.98%270.32K | -41.26%5.8K | 192.65%21.06K | 213.15%166.56K | 532.28%106.99K | 3,418.54%42.5K | -74.44%9.87K | -68.09%7.2K | 17.10%53.19K | 77.06%16.92K |
| Gross profit | 256.67%261.5K | -28.02%9.13K | 53.30%26.34K | 66.22%164.84K | 1,123.03%61.67K | 2,499.82%73.32K | -83.56%12.68K | -61.88%17.18K | 7.53%99.17K | -74.01%5.04K |
| Operating expense | 10.34%2.39M | -67.40%682.08K | -10.82%1.51M | 67.92%8.21M | 67.61%2.25M | 110.97%2.17M | 56.75%2.09M | 19.30%1.69M | -36.84%4.89M | -70.17%1.34M |
| Selling and administrative expenses | 12.43%2.24M | -72.72%522.19K | -11.54%1.34M | 77.37%7.52M | 89.36%2.11M | 120.37%1.99M | 43.36%1.91M | 19.26%1.51M | -19.34%4.24M | -55.52%1.11M |
| -General and administrative expense | 12.43%2.24M | -72.72%522.19K | -11.54%1.34M | 77.37%7.52M | 89.36%2.11M | 120.37%1.99M | --1.91M | 19.26%1.51M | -19.34%4.24M | -55.52%1.11M |
| Depreciation amortization depletion | -12.93%155.42K | -10.52%159.89K | -4.80%172.28K | 5.89%690.84K | -35.74%152.69K | 42.95%178.5K | --178.69K | 19.61%180.96K | -17.48%652.4K | -23.96%237.62K |
| -Depreciation and amortization | -12.93%155.42K | -10.52%159.89K | -4.80%172.28K | 5.89%690.84K | -35.74%152.69K | 42.95%178.5K | --178.69K | 19.61%180.96K | -17.48%652.4K | -23.96%237.62K |
| Other operating expenses | ---- | ---- | ---- | -10.74%-7.25K | ---- | ---- | ---- | ---- | -100.39%-6.55K | ---- |
| Operating profit | -1.73%-2.13M | 67.65%-672.95K | 11.47%-1.48M | -67.95%-8.04M | -63.63%-2.19M | -104.41%-2.1M | -65.36%-2.08M | -21.96%-1.68M | 37.38%-4.79M | 70.15%-1.34M |
| Net non-operating interest income (expenses) | -67.80%-364.24K | -151.88%-765.56K | 1.41%-306.87K | -43.66%-1.24M | -1.83%-313.21K | -19.50%-217.07K | -31.07%-303.94K | -34.98%-311.26K | 29.30%-860.59K | 32.69%-307.59K |
| Non-operating interest expense | 52.42%330.84K | 151.88%765.56K | -1.41%306.87K | 22.23%1.24M | 1.83%313.21K | -10.94%217.07K | 31.07%303.94K | 34.98%311.26K | -17.33%1.01M | -33.59%307.59K |
| Total other finance cost | --33.39K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,339.10%-150.91K | --0 |
| Other net income (expenses) | -1,537.17%-451.32K | 16,398.46%487.65K | 71.50%-35.42K | -169.98%-51.31K | 53.37%-46.27K | 100.03%31.4K | -103.99%-2.99K | -209.65%-124.28K | -95.83%73.33K | -107.30%-99.24K |
| Gain on sale of security | -710.35%-451.72K | -128.56%-10.34K | 65.64%-35.83K | -550.39%-73.54K | 78.48%-21.35K | -455.08%-55.74K | -51.72%36.19K | -525.10%-104.28K | -98.16%16.33K | -120.29%-99.24K |
| Special income (charges) | --0 | 1,370.08%497.58K | --0 | --9.01K | ---30K | --79.01K | ---39.18K | -122.52%-20K | --0 | --0 |
| -Less:Restructuring and mergern&acquisition | --0 | --0 | --0 | ---- | ---- | ---70K | --20K | --20K | ---- | ---- |
| -Less:Other special charges | ---- | -2,694.66%-497.58K | ---- | ---9.01K | --0 | ---9.01K | --19.18K | ---- | ---- | ---- |
| Other non-operating income (expenses) | -95.00%407 | --407 | --407 | -76.82%13.21K | --5.08K | --8.13K | ---- | ---- | --57K | --0 |
| Income before tax | -29.19%-2.95M | 60.16%-950.87K | 13.53%-1.83M | -67.33%-9.33M | -46.08%-2.55M | -91.52%-2.28M | -68.71%-2.39M | -41.58%-2.11M | 21.53%-5.57M | 51.26%-1.74M |
| Income tax | 1,477.61%10.71K | 0 | 0 | 963.10%33.8K | 1,904.09%25.47K | 2,040.00%679 | 7.65K | 0 | 7.54%3.18K | 388.86%1.27K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -29.62%-2.96M | 60.29%-950.87K | 13.53%-1.83M | -67.84%-9.36M | -47.43%-2.57M | -91.58%-2.28M | -69.25%-2.39M | -41.38%-2.11M | 21.52%-5.58M | 51.22%-1.75M |
| Net income continuous operations | -29.62%-2.96M | 60.29%-950.87K | 13.53%-1.83M | -67.84%-9.36M | -47.43%-2.57M | -91.58%-2.28M | -69.25%-2.39M | -41.38%-2.11M | 21.52%-5.58M | 51.22%-1.75M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -29.62%-2.96M | 60.29%-950.87K | 13.48%-1.83M | -67.84%-9.36M | -47.43%-2.57M | -91.58%-2.28M | -69.25%-2.39M | -41.38%-2.11M | 21.52%-5.58M | 51.22%-1.75M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -29.62%-2.96M | 60.29%-950.87K | 13.48%-1.83M | -67.84%-9.36M | -47.43%-2.57M | -91.58%-2.28M | -69.25%-2.39M | -41.38%-2.11M | 21.52%-5.58M | 51.22%-1.75M |
| Diluted earnings per share | -16.67%-0.014 | 73.33%-0.004 | 47.06%-0.009 | 16.67%-0.05 | 52.94%-0.008 | 14.29%-0.012 | 11.76%-0.015 | 0.00%-0.017 | 40.00%-0.06 | 59.15%-0.017 |
| Basic earnings per share | -16.67%-0.014 | 73.33%-0.004 | 47.06%-0.009 | 16.67%-0.05 | 52.94%-0.008 | 14.29%-0.012 | 11.76%-0.015 | 0.00%-0.017 | 40.00%-0.06 | 59.15%-0.017 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.
Unlock Now